Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial
…, J Bohnsack, R Carrasco, J Dare, B Gottlieb, D Wahezi… - The Lancet, 2021 - thelancet.com
Background Tofacitinib is an oral Janus kinase inhibitor. This trial assessed the efficacy and
safety of tofacitinib versus placebo in patients with polyarticular course juvenile idiopathic …
safety of tofacitinib versus placebo in patients with polyarticular course juvenile idiopathic …
Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19
T Tanner, DM Wahezi - Paediatric respiratory reviews, 2020 - Elsevier
The rapid spread of SARS-CoV-2 infection globally coupled with the relatively high case-fatality
rate has led to immediate need for therapeutic intervention to prevent and treat COVID-…
rate has led to immediate need for therapeutic intervention to prevent and treat COVID-…
Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood
…, K Schikler, NG Singer, D Wahezi… - … : Official Journal of …, 2009 - Wiley Online Library
Objective To compare the criteria for Wegener's granulomatosis (WG) of the American
College of Rheumatology (ACR) with those of the European League Against Rheumatism/…
College of Rheumatology (ACR) with those of the European League Against Rheumatism/…
Diagnostic and prognostic tests in systemic lupus erythematosus
N Vasquez-Canizares, D Wahezi… - Best Practice & Research …, 2017 - Elsevier
Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease
characterized by autoantibodies directed against numerous self-nuclear antigens. Because of the …
characterized by autoantibodies directed against numerous self-nuclear antigens. Because of the …
Comparing presenting clinical features in 48 children with microscopic polyangiitis to 183 children who have granulomatosis with polyangiitis (Wegener's): an …
…, E Muscal, K Nanda, DM Wahezi… - Arthritis & …, 2016 - Wiley Online Library
Objective To uniquely classify children with microscopic polyangiitis (MPA), to describe their
demographic characteristics, presenting clinical features, and initial treatments in …
demographic characteristics, presenting clinical features, and initial treatments in …
Clinical characteristics of children with juvenile dermatomyositis: the Childhood Arthritis and Rheumatology Research Alliance Registry
AB Robinson, MF Hoeltzel, DM Wahezi… - Arthritis care & …, 2014 - Wiley Online Library
Objective To investigate aspects of juvenile dermatomyositis (DM), including disease
characteristics and treatment, through a national multicenter registry. Methods Subjects meeting …
characteristics and treatment, through a national multicenter registry. Methods Subjects meeting …
[PDF][PDF] Optimizing the start time of biologics in polyarticular juvenile idiopathic arthritis: a comparative effectiveness study of Childhood Arthritis and Rheumatology …
…, R Vehe, E von Scheven, D Wahezi… - Arthritis & …, 2021 - Wiley Online Library
Objective The optimal time to start biologics in polyarticular juvenile idiopathic arthritis (JIA)
remains uncertain. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) …
remains uncertain. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) …
[HTML][HTML] International validation of a urinary biomarker panel for identification of active lupus nephritis in children
…, C Putterman, D Wahezi, T Rubinstein, D Ekdawy… - Pediatric …, 2017 - Springer
… Non-LN was defined by a renal BILAG2004 score of D or E. This study sought to identify
biomarkers that differentiate between the binary outcome of active versus no LN, therefore renal …
biomarkers that differentiate between the binary outcome of active versus no LN, therefore renal …
American College of Rheumatology guidance for the management of pediatric rheumatic disease during the COVID‐19 pandemic: version 1
DM Wahezi, MS Lo, TB Rubinstein… - Arthritis & …, 2020 - Wiley Online Library
… Wahezi… Wahezi … Wahezi had full access to all of the data in the study and takes
responsibility for the integrity of the data and the accuracy of the data analysis. …
responsibility for the integrity of the data and the accuracy of the data analysis. …
Association of medication access difficulty and COVID‐19–related distress with disease flares in rheumatology patients during the COVID‐19 pandemic
…, E Tu, SN Mahmood, DM Wahezi… - Arthritis care & …, 2021 - Wiley Online Library
Objective Due to concerns of infection and medication disruptions during the COVID‐19
pandemic, rheumatology patients at the pandemic epicenter were at risk of distress and poor …
pandemic, rheumatology patients at the pandemic epicenter were at risk of distress and poor …